DURECT CorporationCupertino, CA United States
Company Description
DURECT wants your medicine to go DURECTly where it's needed. The company is developing drug delivery systems to provide long-term therapy for such conditions as chronic pain, heart disease, cancer, and neurological disorders. Drug delivery technologies provided by DURECT include SABER, a controlled-release injectable; TRANSDUR, a transdermal patch; ORADUR, a sustained release oral gel-cap; DUROS, an osmotic implant; and DURIN, a biodegradable implant. Its R&D efforts are conducted independently and collaboratively. DURECT also sells two commercial products -- biodegradable polymers (Lactel) and osmotic pumps (ALZET) -- to pharmaceutical and medical research firms.
| 2 Results Way | Phone: 408-777-1417 | http://www.durect.com |
| Cupertino, CA 95014 | Fax: 408-777-3577 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
DURECT Corporation Rankings
| Russell 2000 (June 2011) |
Executives
| 24 executives listed for DURECT Corporation's Cupertino, CA location. | ||
| Chairman and Chief Scientific Officer | Felix Theeuwes | |
|---|---|---|
| President, CEO, and Director | James Brown | |
| EVP Operations and Administration | Paula Mendenhall | |
Financials
| Company Type | Public - NASDAQ: DRRX Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 106 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on DURECT Corporation now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
